老虎證券
Invest
Pricing
Rewards
Support
About
Quotes
TigerAI
登入
立即註冊
Toggle
港股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
抗疫概念
878.487
+2.572
0.29%
手動刷新
漲家數：
6
跌家數：
9
平家數：
2
市盈率：
- -
高：
890.706
開：
878.139
低：
871.523
收：
875.916
成交量：
2.29億
成交額：
16.65億
市值：
5,942.94億
流通市值：
4,918.32億
資料載入中...
總覽
新聞資訊
普萊醫藥二次遞表港交所：FIC新藥剛獲批面臨專利到期挑戰、10億對賭債壓頂
蓝鲸财经
·
1小時前
阿里健康(00241)出現大手買入130萬股，成交價$2.92，涉資379.6萬
阿斯达克财经
·
2小時前
人福醫藥上半年淨利增長，索賠持續徵集中
市场资讯
·
3小時前
創勝集團醫藥－Ｂ(06628)股價上升6.667%，現價港幣$0.88
阿斯达克财经
·
6小時前
港股異動 | 中國生物製藥(01177)漲近3% TQH2722、TQB2102新藥上市申請雙雙獲受理
智通财经
·
8小時前
創新藥概念局部走強 恒瑞醫藥（01276）漲2.74% 機構料企業扭虧節點到來
金吾财讯
·
8小時前
《股市簡訊》中國生物製藥升3%，TQH2722注射液新藥上市申請獲得受理
路透中文
·
8小時前
港股開盤 | 恒指高開0.50% 舜宇光學科技(02382)升逾2% 寧德時代(03750)跌超2%
智通财经
·
8小時前
港股指數小幅高開 恒指升0.5% 新東方-S（09901）漲4.33%
金吾财讯
·
9小時前
中生製藥(01177.HK)TQH2722注射液新藥上市申請獲得受理
阿斯达克财经
·
9小時前
中國生物製藥(01177.HK)：TQH2722注射液「IL-4Rα單抗」新藥上市申請獲得受理
智通财经
·
11小時前
中國生物製藥(01177)：TQB2102注射液「HER2雙表位雙抗ADC」新藥上市申請獲得受理
智通财经
·
11小時前
中國中藥(00570.HK)附屬簽訂車間改造項目工程總承包合同及產能提升技術改造項目工程總承包合同
智通财经
·
昨天
中國中藥旗下子公司簽約山東益方改造項目，合同金額1060萬元及其他事項
美股速递
·
昨天
阿里健康(00241)授出合共767.25萬個受限制股份單位
智通财经
·
昨天
董事長兼總裁吳豫生增持同源康醫藥-B(02410.HK)40萬股 每股作價約2.82港元
智通财经
·
昨天
石藥集團(01093)：SYS 6010於中國獲國家藥監局納入突破性治療品種名單用於治療驅動基因陰性非鱗狀非小細胞肺癌患者
智通财经
·
昨天
復星醫藥：9月15日回購130萬股股份
格隆汇
·
昨天
勁方醫藥-B(02595)9月15日斥資129.56萬港元回購5萬股
智通财经
·
昨天
復星醫藥(02196.HK)周二回購130萬股 涉2,207萬元
阿斯达克财经
·
昨天
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/BK1515/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"BK1515","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","market":"HK","secType":"PLATE","nameCN":"抗疫概念","latestPrice":878.48724,"timestamp":1789546124622,"preClose":875.9157,"halted":0,"volume":229256212,"delay":0,"changeRate":0.002936,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盤","change":2.571533,"latestTime":"09-16 16:00:00","open":878.13885,"high":890.7062,"low":871.5229,"amount":1664552354,"amplitude":0.021901,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1789608600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1789522200000,1789531200000],[1789534800000,1789545600000]],"pbRate":1.316272,"peRate":17.057675,"turnoverRate":0.002983,"increases":7,"decrements":9,"flats":1,"marketCap":594294408000,"floatMarketCap":491832141504},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","high":890.7062,"amplitude":0.021901,"preClose":875.9157,"low":871.5229,"pbRate":"1.316272","latestPrice":878.48724,"volume":229256212,"delay":0,"open":878.13885,"prevYearClose":1190.107,"prevWeekClose":878.789,"prevMonthClose":925.265,"prevQuarterClose":802.777,"fiveDayClose":912.778,"twentyDayClose":905.419,"sixtyDayClose":815.098,"secType":"PLATE","market":"HK","turnoverRate":0.002983,"peRate":17.057675,"marketCap":594294408000,"floatMarketCap":491832141504,"timestamp":1789546124622,"nameCN":"抗疫概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1515\",,,,undefined,":{"bkCode":"BK1515","up":6,"down":9,"flat":2},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1515\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667427609","title":"普萊醫藥二次遞表港交所：FIC新藥剛獲批面臨專利到期挑戰、10億對賭債壓頂","url":"https://stock-news.laohu8.com/highlight/detail?id=2667427609","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667427609?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 17:08","pubTimestamp":1789549731,"startTime":"0","endTime":"0","summary":"根据招股书披露，普莱医药2007年获得独家许可的化合物专利，在中国已于2025年12月到期。根据招股书，普莱医药已在中国完成PL-3301的一项Ia期临床试验，且已于2024年获FDA批准在美国进行I期临床试验。截至2026年6月30日，普莱医药的股权赎回负债高达10.82亿元，负债净额8.19亿元，处于资不抵债状态。而普莱医药目前的收入几乎空白。普莱医药此次的IPO，本质上是一场与专利到期和现金耗尽的双重赛跑。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1789549703563671154","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["159938","BK1515","BK1574","BK1161","IPOS","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667606891","title":"阿里健康(00241)出現大手買入130萬股，成交價$2.92，涉資379.6萬","url":"https://stock-news.laohu8.com/highlight/detail?id=2667606891","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667606891?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 15:59","pubTimestamp":1789545540,"startTime":"0","endTime":"0","summary":"[大手成交]阿里健康(00241)在下午03:59出现大手买入，成交量为130万，成交价为港币$2.92，涉资379.6万。至目前为止，股价跌0.342%，今日最高价为$2.935，而最低价为$2.885，总成交量为5.07千万股，总成交金额港币$1.475亿。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180815142908460_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180815142908460_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAV2609165604/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAV2609165604/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1142","BK1247","BK1189","HK0000165453.HKD","BK1610","BK1501","00241","BK1502","BK1515","BK1584","BK1589","BK1591","BK1615","BK1617","BK1571"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667860371","title":"人福醫藥上半年淨利增長，索賠持續徵集中","url":"https://stock-news.laohu8.com/highlight/detail?id=2667860371","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667860371?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 15:35","pubTimestamp":1789544100,"startTime":"0","endTime":"0","summary":"上半年，公司实现营业收入120.61亿元，同比下降0.03%；归属于上市公司股东的净利润为13.3亿元，同比增长15.15%；归属于上市公司股东的扣除非经常性损益的净利润为12.89亿元，同比增长14.02%。净利润增长之外，人福医药还处于被证监会立案调查之中。2024年10月22日，人福医药披露公告称公司及控股股东收到中国证监会《立案告知书》，因涉嫌信息披露违法违规，中国证监会决定对公司及控股股东立案。受损投资者可积极维护自身合法权益，加入维权挽回损失。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/gmwq/rightscase/2026-09-16/doc-inirzfsz4836844.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","09939","BK1161","BK1515","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667224674","title":"創勝集團醫藥－Ｂ(06628)股價上升6.667%，現價港幣$0.88","url":"https://stock-news.laohu8.com/highlight/detail?id=2667224674","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667224674?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 11:58","pubTimestamp":1789531080,"startTime":"0","endTime":"0","summary":"[上升股]创胜集团医药－Ｂ(06628) 股价在上午11:57比前收市价上升6.667%，现股价为港币$0.88。至目前为止，今日最高价为$0.88，而最低价为$0.78。总成交量为25.2万股，总成交金额为港币$20.738万。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20190515141041255_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20190515141041255_s.png"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2609161589/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2609161589/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1574","159938","BK1515","09939","06628","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667679600","title":"港股異動 | 中國生物製藥(01177)漲近3% TQH2722、TQB2102新藥上市申請雙雙獲受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2667679600","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667679600?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 10:31","pubTimestamp":1789525861,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，中国生物制药涨近3%，截至发稿，涨1.94%，报5.525港元，成交额1.04亿港元。消息面上，9月16日，中国生物制药发布公告，本集团附属公司正大天晴药业集团股份有限公司自主研发的国家1类创新药TQH2722注射液“IL-4Rα单抗”已向中国国家药品监督管理局药品审评中心递交新药上市申请并获得受理，用于外用药控制不佳或不适合外用药治疗的成人中重度特应性皮炎 。此次新药上市申请获受理是基于TQH2722-III-01研究取得的积极临床结果。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1496643.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1521","01177","VXUS","IPOS","BK1191","BK4585","IE00BZ08YT58.USD","BK4588","IE00BZ08YS42.EUR","KCAI","HK0000165453.HKD","BK1515","BK1589","IE00BZ08YR35.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667617679","title":"創新藥概念局部走強 恒瑞醫藥（01276）漲2.74% 機構料企業扭虧節點到來","url":"https://stock-news.laohu8.com/highlight/detail?id=2667617679","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667617679?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 10:20","pubTimestamp":1789525259,"startTime":"0","endTime":"0","summary":"消息面上，国金证券表示，创新药企业扭亏节点到来，全年临床数据催化密集，叠加已BD出海管线海外临床进展顺利，看好创新药板块投资机会。诚通证券表示，2025年为创新药海外授权BD大年，2026H1我国创新药海外授权BD交易继续大幅增长，总交易金额已接近1000亿美元，国产创新药已从偶发性出海转变为系统性趋势。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250110/NTQxOTRlZTU5ZGZkZjc4MmEzMTdjMTVhMTM1NjYxOTg3NzU=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/NTQxOTRlZTU5ZGZkZjc4MmEzMTdjMTVhMTM1NjYxOTg3NzU=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1991724","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0516423174.USD","LU0348827113.USD","LNGR","LU2148510915.USD","LU1328615791.USD","LU0043850808.USD","09688","BK0060","01477","159992","LU0307460666.USD","01177","06978","LU0359201612.USD","LU1655091616.SGD","BK1574","LU1255011170.USD","BK1515","LU0456846285.SGD","LU0516422952.EUR","KURE","LU2097828557.USD","LU0327786744.USD","LU0417516902.SGD","LU1023057109.AUD","MEDX","IE00BZ08YS42.EUR","IE00B0JY6N72.USD","LU0405327148.USD","LU2039709279.SGD","LU0588546209.SGD","LU2097828805.USD","600276","LU0140636845.USD","LU0128526141.USD","02269","LU0561508036.HKD","LU2580892789.USD","LU1820825898.SGD","LU1997244956.HKD","BK0188","BK0183","LU2488822045.USD","LU1146622755.USD","LU1580142542.USD","01276","LU0348825331.USD","IBBQ","02637","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667767156","title":"《股市簡訊》中國生物製藥升3%，TQH2722注射液新藥上市申請獲得受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2667767156","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667767156?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 10:14","pubTimestamp":1789524890,"startTime":"0","endTime":"0","summary":"《股市简讯》中国生物制药升3%，TQH2722注射液新药上市申请获得受理* 泰国富豪谢氏家族旗下制药公司--中国生物制药1177.HK周三早盘一度升3%，TQH2722注射液新药上市申请获得受理。* 该公司公告称，附属公司正大天晴药业集团自主研发的国家1类创新药TQH2722注射液“IL4Rα单抗”已向中国国家药品监督管理局药品审评中心递交新药上市申请并获得受理，用于外用药控制不佳或不适合外用药治疗的成人中重度特应性皮炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nL4S45804G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000165453.HKD","IE00BZ08YR35.GBP","01177","BK1589","IE00BZ08YT58.USD","BK1515","BK1191","BK1521","IE00BZ08YS42.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667763476","title":"港股開盤 | 恒指高開0.50% 舜宇光學科技(02382)升逾2% 寧德時代(03750)跌超2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2667763476","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667763476?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 09:44","pubTimestamp":1789523097,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，9月16日，恒生指数高开0.50%，报24,789.91点；恒生科技指数涨0.47%，报4,311.70点；国企指数涨0.45%，报8,241.59点。盘面上，光学及电脑硬件股走强，丘钛科技涨2.49%，舜宇光学科技涨2.38%，联想集团涨2.24%；医药电商股京东健康涨2.87%，中国生物制药涨1.48%；乳业股蒙牛乳业涨2.17%；公用股方面，中电控股涨2.02%，香港中华煤气涨1.34%；黄金珠宝股老铺黄金涨1.12%，周大福涨2.34%。恒生指数成分股中，宁德时代跌2.03%，跌幅靠前。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1496616.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0348784397.USD","HHImain","BK1571","LU1808992512.USD","06618","LU0251143458.SGD","LU0345775950.USD","LU0672654166.SGD","LU0029874905.USD","LU0823041008.USD","LU0117841782.USD","LU0329678170.USD","SBHMY","LU1733274473.HKD","LU0449509016.USD","LU2663582299.SGD","BK1527","LU0315178854.USD","LU1770036033.HKD","BK1142","SG9999001069.SGD","LU1769817179.HKD","LU1226288253.USD","LU1366334578.USD","LU0328353924.USD","07200","LU0543330566.HKD","BK1545","LU1814569148.SGD","01478","LU1251922891.USD","02837","SG9999018857.SGD","LU0501845795.SGD","IE0001KFT4U8.USD","BK1553","LU0823426480.USD","BK1597","LU0823426308.USD","IE00BQXX3D17.EUR","HK0000914686.HKD","09088","LU1770034418.SGD","LU1226287875.USD","LU0828237940.HKD","JADE","LU0449515922.USD","06181","LU0588546209.SGD","LU0828237510.HKD","LU0577902454.USD","IE0032834883.USD","LU0039217434.USD","LU1196710195.USD","BK1590","LU1810669033.SGD","LU0107464264.USD","BK1515","TCEHY","HSI","LU0228367735.SGD","LU1051768304.USD","CLPHY","LU0384037296.USD","LU2039709279.SGD","LU0651946864.USD","LU0061477393.USD","HXXD.SI","LU0633140560.USD","LU0370786039.SGD","LU0348735423.USD","BK1615","LU0577902611.USD","BK1602","03416","LU0320764243.SGD","LU0588545490.SGD","LU0499858438.USD","HK0001040143.USD","SGXZ90724238.SGD","LU0320764755.SGD","LU2279701549.SGD","LU0348723411.USD","IE0003851619.USD","LU0886674414.USD","LU2237443895.HKD","LU0577902298.EUR","SG9999000418.SGD","DRGN","BK1521","513600","LU1508157978.USD","LU0127658192.USD","SG9999015978.USD","LU0608807433.USD","SG9999014674.SGD","LU1691799644.USD","MIUmain","LU0441854154.USD","LU0329678337.USD","BK1116","BK1502","LU1880383440.USD","SG9999015986.USD","LU0173614495.USD","BK1224","LU0463099449.HKD","81024","LU0738912210.USD","LU0708995583.HKD","EMCS","01024","LU1629966141.USD","LU2279858448.HKD","IE00BGV7N243.SGD","LU0396098781.USD","03032","LU1267930227.SGD","LU0143863784.USD","LU0561508036.HKD","IE0003795394.USD","LU1993786604.SGD","HK0000165453.HKD","LU0251144936.SGD","HK0000288743.USD","LU0348816934.USD","LU1769817096.USD","LU0029875118.USD","BK1506","LU0106252389.USD","LU1917777945.USD","BK1099","IE0003895053.USD","LU1868838027.USD","LU0054450605.USD","LU3227948356.SGD","IE00B97KM107.HKD","IE0031814852.USD","SGXZ99366536.SGD","BIDD","LU0823038988.USD","LU0043850808.USD","LU0823397285.USD","LU2023250504.SGD","LU0877626530.USD","LU2247934214.USD","LU1152091168.USD","LU1235295612.USD","LU0797268264.HKD","BK1618","LU1242518857.USD","SG9999002463.SGD","02802","CXSE","LU0648948544.HKD","LU0307460666.USD","LU0320764599.SGD","09067","LU1023057109.AUD","LU0823039010.USD","02833","SG9999006514.SGD","BK1227","01177","LU1439102457.SGD","BK1237","LU1655091459.SGD","IE00B0169L03.USD","LU0049112450.USD","LU1718418525.SGD","SGXZ62798434.SGD","TCHI","LU0456846285.SGD","LU0264606111.USD","LU0499858602.USD","LU0345769128.USD","SGXZ86797644.SGD","HK0000320223.HKD","LU0348766576.USD","LU2317271919.USD","BK1193","LU0359202008.SGD","LU2152927971.USD","LU0359201885.HKD","81810","IE00B0169N27.USD","LU1961090484.USD","LU0211977185.USD","LU2148510915.USD","80992","LU2257852520.SGD","LU2449936058.SGD","LU2177674079.SGD","BK1179","LU0708995153.HKD","SG9999002828.SGD","HOKCY","KWEB","IE00BQXX3C00.GBP","LU0572940350.SGD","SG9999000327.SGD","LNVGY","LU1497734951.SGD","LU0128525689.USD","LU0608807946.USD","SG9999015952.SGD","LU0210527791.USD","LU0348788117.USD","LU0572944931.SGD","LU0823040885.USD","BKF","LU0261950983.USD","IE00B29SXG58.USD","LU0819121731.USD","LU2778985437.USD","LU0642271901.SGD","LU0348783233.USD","XSOE","SG9999001051.SGD","LU1725190679.HKD","BK1170","LU0985320562.USD","SG9999001846.SGD","LU0456827905.SGD","LU0070217475.USD","HK0000352291.HKD","IE00B8HQ1Z84.USD","BK1608","83115","LU0348783662.USD","LU2106854487.HKD","LU1733274390.USD","LU2362541513.USD","02319","LU1642822792.SGD","LU0048597586.USD","LU0633140727.USD","LU1102505762.USD","LU2237443978.SGD","LU1196710864.SGD","MCHmain","SG9999014914.USD","LU1226287529.USD","LU0531971595.HKD","BK1586","BK1601","CJEWY","LU1568876251.USD","LU0192582467.USD","LU3063872942.SGD","00002","07500","LU0175139822.USD","LU0345769631.USD","LU1211504680.USD","LU0516422366.SGD","LU1226288097.SGD","LU0702159699.USD","LU1044875133.USD","LU0589944569.HKD","LU0293314216.USD","09115","XIACY","LU1044874839.SGD","LU0594300179.USD","IE00BZ08YR35.GBP","LU1188198961.HKD","LU0868486357.SGD","HK0000151867.HKD","LU0314109678.HKD","IE0008368742.USD","IE0032431581.USD","IE00B5MMRT66.SGD","SG9999018865.SGD","86618","EEMX","LU0873338254.USD","LU0140636845.USD","ODDS","LU0228659784.USD","BK1247","LU0054237671.USD","LU2498475776.HKD","LU1813983027.USD","LU1242518931.SGD","SGXZ31699556.SGD","LU1051769294.HKD","LU0509642566.USD","SG9999001226.SGD","LU0052750758.USD","LU0117844026.USD","HK0000914660.USD","LU0607220059.USD","00003","LU0737861699.HKD","ESPO","IE00BYQNZ168.SGD","LU2462611646.USD","LDEM","LU0650527681.SGD","SG9999002562.SGD","LU0821914370.USD","07552","BK1191","LU0048388663.USD","GB00BDT5M118.USD","LU2045819591.USD","LU0890818403.SGD","LU1719994722.HKD","LU0918141887.USD","LU1688375341.USD","LU0106959298.USD","03419","LU0516423174.USD","BK1577","LU0244354667.USD","CIADY","LU0791590937.USD","LU0310800965.SGD","LU0326950275.SGD","LU0096374516.USD","LU0431992006.USD","LU0203347892.USD","HSTECH","SG9999000459.SGD","IE00B3M56506.USD","SG9999004220.SGD","BK1591","LU0211331839.USD","LU0047713382.USD","LU0417516738.SGD","07588","LU1282649067.USD","07288","LU2133065610.SGD","BK1583","IE0008368411.USD","IE00BYTNYN87.SGD","LU0594300419.USD","LU1634259391.SGD","LU0593848301.USD","LU0289960550.SGD","LU0831103253.SGD","SG9999015945.SGD","02800","LU0229945570.USD","LU2362541273.HKD","LU0634319403.HKD","IE00BQXX3F31.USD","IE00BZ08YS42.EUR","LU0165289439.USD","LU2087589342.USD","LU0326948709.USD","LU0080751232.USD","LU0469268626.HKD","BK1504","LU0132412106.USD","03037","LU0878005551.USD","LU0231483743.USD","LU0502904849.HKD","IE0008369823.USD","LU0878004406.USD","LU0541502299.USD","LU0972618739.USD","BK1609","KSTmain","SG9999001093.SGD","BK1607","LU2293587155.HKD","SG9999001689.USD","LU0862451837.USD","LU1282649810.SGD","LU1048588211.SGD","LU2265009873.SGD","SG9999014898.SGD","BK1221","LU2362540622.SGD","LU0455707207.USD","IE00BZ08YT58.USD","BK1096","LU0210526637.USD","LU0516422440.USD","LU0106259558.USD","LU2476274720.SGD","SG9999001903.USD","LU0577902538.SGD","LU1981816686.USD","LU0164872284.USD","LU1366334651.USD","LU0823413587.USD","LU1515016050.SGD","LU1316542783.SGD","HK0001040168.HKD","02828","LU1522347837.USD","LU0214875030.USD","LU2226246903.HKD","LU0348827113.USD","LU0683595622.HKD","LU2251237306.USD","LU2097828474.EUR","LU1883866441.USD","LU0898667661.SGD","LU2237443382.USD","LU0791591158.USD","IE00B0JY6N72.USD","LU0149534421.HKD","LU0516423091.SGD","LU2097828805.USD","LU0979878070.USD","LU2097828631.EUR","300750","LU0164880469.USD","LU0348805143.USD","LU0588545730.USD","LU1880383366.USD","LU0163747925.USD","LU2008162690.USD","LU0149721374.USD","IE00B031J352.USD","00700","LU0540923850.HKD","IE00B031HW06.USD","LU1785774172.SGD","LU0856984785.SGD","LU0865486749.SGD","01810","JEMA","LU1102505929.USD","IE00BG0RBZ43.SGD","LU1105468828.SGD","AAXJ","LU1734074674.USD","LU1868837722.USD","LU0169518387.USD","LU0067412154.USD","LU0052756011.USD","LU0572939691.SGD","LU1226288170.HKD","IE00B8L5B284.USD","LU2097828557.USD","LU0702159343.USD","LU0651947912.USD","LU2237443622.USD","03423","LU0261947096.USD","LU1048484197.HKD","LU1960683339.HKD","LU2251237488.HKD","LU0784639295.USD","IE00B067MR52.USD","SG9999013353.USD","LU2476274308.USD","LU0051755006.USD","LU0516422952.EUR","LU0254981946.USD","FFEM","03145","LU1481107354.HKD","LU0128522157.USD","LU0786609619.USD","LU0640798160.USD","SG9999014880.SGD","LU0543330483.HKD","LU2097828714.EUR","LU1119993845.HKD","03417","SG9999003461.SGD","LU0541501648.USD","HK0000286598.CNH","LU0259732245.USD","LU0143863198.USD","LU1568876335.HKD","LU0210533765.USD","LU0181495838.USD","LU0196878994.USD","LU0577902371.SGD","HK0000306701.USD","LU0385154629.USD","LU0417516571.SGD","LU1008478684.HKD","LU0819123356.HKD","IE00BPRC5H50.USD","00992","LU1807302812.USD","82828","IE0034224299.USD","LU0918141705.HKD","LU1226287792.SGD","LU0359201612.USD","LU1064130708.USD","LU2237443549.SGD","LU0588545904.SGD","HK0000306685.HKD","LU0488056044.USD","BK1095","BK1516","BK1575","LU1323998911.USD","HK0000320264.USD","LU0823397103.USD","LU0287142896.SGD","03067","07226","LU1303224171.USD","LU0414403682.SGD","IE00B031HY20.USD","LU0072462343.USD","LU0700851271.USD","02382","LU0188438112.USD","LU0882747503.HKD","SG9999006597.SGD","LU0315179316.USD","LU0417516902.SGD","LU0084288322.USD","IE00BHRH8C09.USD","LU1152091754.HKD","LU1328277881.USD","HTCD.SI","IE0009570106.USD","LU0675040207.SGD","LU1868837565.USD","IE00B12V2V27.USD","LU0235996351.USD","LU0327786744.USD","GAMR","03033","07300","LU0471298777.SGD","TCHmain","LU1044876610.USD","LU1634259557.SGD","FDNI","LU1282649141.HKD","HSCEI","LU0531970944.HKD","LU1497733557.USD","LU2294711473.HKD","LU1831875114.USD","SGXZ51526630.SGD","LU1720050803.USD","LU1064131003.USD","03750","LU2125910500.SGD","LU0128522744.USD","LU0611395673.USD","IE00BF5LJ272.USD","LU1974910355.USD","BK1531","HK0000288784.HKD","LU0348767384.USD","LU1224444064.USD","LU1282651048.USD","LU2237443465.HKD","LU0828238088.HKD","BK1517","LU1046422090.SGD","LU1504937902.USD","03088","SOCL","LU2399975544.HKD","LU0205439572.USD","LU2051468812.USD","LU1171460220.USD","LU0345776255.USD","LU1328615791.USD","BK1589","LU1951186391.HKD","SG9999014906.USD","BK1544","LU1794554557.SGD","LU1224709979.USD","LU0164865239.USD","IE00B543WZ88.USD","LU0048580855.USD","LU0072913022.USD","LU1048596156.SGD","LU0871576103.HKD","BK1526","LU0348825331.USD","LU0011963245.USD","LU1196710351.USD","82800","LU0737861772.HKD","LU0049853897.USD","LU1439103000.SGD","HK0000352382.USD","LU1282651121.HKD","LU1497733631.SGD","LU0862451753.SGD","LU2125910849.SGD","BK1523","LU0823413660.USD","LU1166156734.SGD","01929","03115","BK1610","LU1956131251.USD","LU0605514214.HKD","LU1115378108.SGD","LU0880133367.SGD","LU1804176565.USD","LU0269904917.USD","LU0203345920.USD","SGXZ81514606.USD","LU1675838814.USD","LU0348814723.USD","LU1282648689.USD","LU2242644610.SGD","SG9999011746.SGD","LU0456842615.SGD","SG9999017495.SGD","SG9999007991.SGD","EMC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667675404","title":"港股指數小幅高開 恒指升0.5% 新東方-S（09901）漲4.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2667675404","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667675404?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 09:29","pubTimestamp":1789522154,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股指数小幅高开，恒指升0.5%，国企指数升0.45%，恒生科技指数升0.47%。港湾家族办公室业务发展总监郭家耀表示，美股周二继续向下，美国长债息率持续上升，不利市场气氛，三大指数均录得跌幅收市。内地股市昨日下跌，沪综指低开低走，收市下跌0.5%，沪深两市成交额进一步缩减。港股跟随外围下跌，油价及债息持续上升，拖累大市表现，指数高开低走，整体成交保持清淡。","market":"fut","thumbnail":"https://static.szfiu.com/news/20200915/NzYyNDljMmIwNjZjMTQ3MTljY2ZkYmY1MDAwNDcwMjMxMA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20200915/NzYyNDljMmIwNjZjMTQ3MTljY2ZkYmY1MDAwNDcwMjMxMA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1991712","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1610","BK1227","BK1521","BK1183","LU1497733631.SGD","CKISY","LU1831875114.USD","02057","BK1116","BK1596","SG9999001051.SGD","BK1170","LU2517655028.SGD","FTEC","LU1634259391.SGD","BK1099","01929","LU0823426480.USD","02833","LU0067412154.USD","BK1519","IE00BZ08YR35.GBP","BK1601","BK1237","LU0274383008.USD","HSI","SG9999011746.SGD","SGXZ86797644.SGD","MNQmain","QDTE","BK1545","SQQQ","QQQA","LU1580142542.USD","TQQQ","LU1522347837.USD","BK1543","07200","BK1571","BK0028","IE00B0JY6N72.USD","03750","01038","LU0531971595.HKD","IE00B29SXG58.USD","BK1615","IE00BYQNZ168.SGD","LU1102505929.USD","LU0650527681.SGD","LU0572944931.SGD","82800","IE00BZ08YT58.USD","GPIQ","EDU","SG9999001226.SGD","LU0072462343.USD","JEPQ","BK1588","BK1515","HK0000288784.HKD","LU0287142896.SGD","LU1634259557.SGD","HK0000288743.USD","01377","BK1224","LU0501845795.SGD","09115","03067","03088","LU0702159699.USD","BK1504","TECS","BK1602","LU0880133367.SGD","02382","BK0183","301377","LU0456827905.SGD","LU2045819591.USD","QLD","BK1589","LU0164865239.USD","NDX","QQQ","HHImain","SG9999006597.SGD","82331","BK1569","LU1655091616.SGD","LU1008478684.HKD","IYW","SG9999001069.SGD","LU1166156734.SGD","BK0201","LU0327786744.USD","BK1228","ONEQ","LU0307460666.USD","07300","LU0359202008.SGD","03115","LU0594300179.USD","LU0051755006.USD","QQQY","01519","03419","SGXZ62798434.SGD","09067","BK0012","BK1591","BK1608","IE00BZ08YS42.EUR","LU0348805143.USD","LU0326950275.SGD","QQQE","LU0072913022.USD","LU1226287529.USD","LU1781817850.SGD","LU2929501877.USD","NVIW.SI","IE0008369823.USD","LU0823426308.USD","LU1993786604.SGD","09088","IE0034224299.USD","LU0039217434.USD",".IXIC","MCHmain","LNNGY","02800","IE0031814852.USD","BK0188","LU1960683339.HKD","LU0048580855.USD","BK1556","LU0541501648.USD","QQQM","LU1152091754.HKD","BK1575","IE00B12V2V27.USD","LU0588546209.SGD","SGXZ90724238.SGD","03086","NQmain","LU1102505762.USD","LU1807302812.USD","TQQY","LU1497733557.USD","BK1583","HSTECH","07552","LU0359201885.HKD","LU2517655374.HKD","IE0008368742.USD","03417","03033","BK1142","CJEWY","LU1211504680.USD","02331","LU2187417386.USD","07500","LU2351347302.SGD","03032","BK1541","BK1247","BK1603","LU1152091168.USD","BK1151","SG9999002950.SGD","07226","BK1502","LU2125910500.SGD","LU2517655291.USD","QQQJ","HK0000165453.HKD","LU1048588211.SGD","06618","LU0541502299.USD","83115","BK1191","300750","LU0359201612.USD","BK0278","03423","LU0173614495.USD","LU1880383366.USD","WHGLY","BK0187","IE00B031HY20.USD","01177",".HXC","03037","LU1969619763.USD","QYLG","000001","513600","BK1512","LU0370786039.SGD","09901","LU0593848301.USD","LU1497734951.SGD","SG9999001093.SGD","LU0605514214.HKD","PSQ","QID","SBHMY","LU1023057109.AUD","LU0594300419.USD","ZTO","IE00BYTNYN87.SGD","LU2328871848.SGD","00288","02837","86618","LU0871576103.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667732986","title":"中生製藥(01177.HK)TQH2722注射液新藥上市申請獲得受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2667732986","media":"阿斯达克财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667732986?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 08:47","pubTimestamp":1789519620,"startTime":"0","endTime":"0","summary":"中生制药公布，附属公司正大天晴药业集团自主研发的国家1类创新药TQH2722注射液“IL-4Rα单抗”已向中国国家药品监督管理局药品审评中心递交新药上市申请并获得受理，用于外用药控制不佳或不适合外用药治疗的成人中重度特应性皮炎。TQH2722是一款靶向白细胞介素4受体α的全人源单克隆抗体，有助降低2型炎症相关病理反应。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20220728114526454_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20220728114526454_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1544640/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1544640/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["HK0000165453.HKD","IE00BZ08YR35.GBP","IE00BZ08YS42.EUR","IE00BZ08YT58.USD","BK1574","01177","BK1191","BK1515","01477","BK1589","BK1521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667562067","title":"中國生物製藥(01177.HK)：TQH2722注射液「IL-4Rα單抗」新藥上市申請獲得受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2667562067","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667562067?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 07:18","pubTimestamp":1789514320,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["HK0000165453.HKD","IE00BZ08YT58.USD","BK1515","IE00BZ08YR35.GBP","01177","BK1191","IE00BZ08YS42.EUR","BK1521","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667620546","title":"中國生物製藥(01177)：TQB2102注射液「HER2雙表位雙抗ADC」新藥上市申請獲得受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2667620546","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667620546?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 07:15","pubTimestamp":1789514109,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国生物制药 发布公告，本集团附属公司正大天晴药业集团股份有限公司自主研发的国家1类创新药TQB2102注射液“HER2双表位双抗ADC”已向中国国家药品监督管理局药品审评中心递交新药上市申请并获得受理，用于既往在复发或转移性疾病阶段未接受过化疗的不可切除或转移性HER2低表达成人乳腺癌患者。TQB2102是全球首个在HER2低表达乳腺癌III期临床中取得阳性结果的HER2双表位双抗ADC。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1496572.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1521","BK1589","BK1191","HK0000165453.HKD","IE00BZ08YT58.USD","IE00BZ08YS42.EUR","01177","IPOS","IE00BZ08YR35.GBP","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667642784","title":"中國中藥(00570.HK)附屬簽訂車間改造項目工程總承包合同及產能提升技術改造項目工程總承包合同","url":"https://stock-news.laohu8.com/highlight/detail?id=2667642784","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667642784?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 20:32","pubTimestamp":1789475579,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["00570","BK1515","BK1606","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102382871","title":"中國中藥旗下子公司簽約山東益方改造項目，合同金額1060萬元及其他事項","url":"https://stock-news.laohu8.com/highlight/detail?id=1102382871","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102382871?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 20:31","pubTimestamp":1789475470,"startTime":"0","endTime":"0","summary":"中国中药发布公告称，其子公司精方药业已就山东益方改造项目达成承包协议。该项目合同总金额为人民币1060万元。值得注意的是，此次签约标志着公司在区域业务拓展上迈出了新的一步。除这一核心项目外，公告还披露了其他相关事项，进一步丰富了本次信息披露的内容维度。需关注的是，合同履行过程中仍存在原材料价格波动、施工进度不确定性等潜在风险因素。公司表示，将严格按照合同条款推进项目执行，确保按期保质完成各项建设任务。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1606","00570","BK1515","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667644950","title":"阿里健康(00241)授出合共767.25萬個受限制股份單位","url":"https://stock-news.laohu8.com/highlight/detail?id=2667644950","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667644950?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 19:50","pubTimestamp":1789473031,"startTime":"0","endTime":"0","summary":"智通财经APP讯，阿里健康(00241)发布公告，于2026年9月15日，公司根据2024年股份奖励计划得条款向16名承授人授出合共767.25万个受限制股份单位，但须待接纳后方可作实。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1496427.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1142","BK1617","BK1615","BK1247","BK1589","HK0000165453.HKD","BK1502","BK1515","BK1610","BK1591","00241","BK1584","BK1571","BK1189","BK1501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667641986","title":"董事長兼總裁吳豫生增持同源康醫藥-B(02410.HK)40萬股 每股作價約2.82港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2667641986","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667641986?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 19:07","pubTimestamp":1789470429,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["09939","BK1574","02410","BK1161","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667645058","title":"石藥集團(01093)：SYS 6010於中國獲國家藥監局納入突破性治療品種名單用於治療驅動基因陰性非鱗狀非小細胞肺癌患者","url":"https://stock-news.laohu8.com/highlight/detail?id=2667645058","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667645058?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 18:04","pubTimestamp":1789466653,"startTime":"0","endTime":"0","summary":"智通财经APP讯，石药集团 发布公告，集团开发的SYS 6010近日获中华人民共和国国家药品监督管理局纳入突破性治疗品种名单，拟定适应症为既往接受过免疫治疗及含铂化疗治疗失败的复发或转移性驱动基因阴性非鳞状非小细胞肺癌。目前，评估该产品单药用于经标准治疗失败的驱动基因阴性局部晚期或转移性非鳞状非小细胞肺癌的随机、开放、多中心III期临床试验正在开展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1496306.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"石药集团(01093)：SYS 6010于中国获国家药监局纳入突破性治疗品种名单用于治疗驱动基因阴性非鳞状非小细胞肺癌患者","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HK0000165453.HKD","IE00B543WZ88.USD","LU0880133367.SGD","LU0067412154.USD","IE00BZ08YS42.EUR","LU2039709279.SGD","BK1191","LU1813983027.USD","LU0315179316.USD","BK1521","LU1152091754.HKD","IE00B031HY20.USD","LU1226287529.USD","01093","SG9999004220.SGD","LU1008478684.HKD","IE00BZ08YR35.GBP","BK1515","LU1226287875.USD","LU1993786604.SGD","LU0501845795.SGD","LU0072913022.USD","LU1226287792.SGD","LU0314109678.HKD","LU1328277881.USD","LU1951186391.HKD","LU1226288253.USD","IE00B5MMRT66.SGD","LU1152091168.USD","LU0326950275.SGD","IE0008369823.USD","LU0140636845.USD","IE00BZ08YT58.USD","LU1226288170.HKD","KURE","LU1807302812.USD","LU1960683339.HKD","IE0008368742.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667936645","title":"復星醫藥：9月15日回購130萬股股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2667936645","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667936645?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 17:58","pubTimestamp":1789466293,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK1593","02196","BK1191","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667664559","title":"勁方醫藥-B(02595)9月15日斥資129.56萬港元回購5萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2667664559","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667664559?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 17:50","pubTimestamp":1789465841,"startTime":"0","endTime":"0","summary":"智通财经APP讯，劲方医药-B(02595)发布公告，于2026年9月15日，该公司斥资129.56万港元回购5万股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1496282.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02595","BK1515","159938","09939","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667645208","title":"復星醫藥(02196.HK)周二回購130萬股 涉2,207萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2667645208","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667645208?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 17:49","pubTimestamp":1789465740,"startTime":"0","endTime":"0","summary":"复星医药(02196.HK) 公布，于9月15日回购130万股，每股作价介乎16.89至17.1元，涉资约2,207.07万元。(da)(港股报价延迟最少十五分钟。沽空资料截至 2026-09-15 16:25。)AASTOCKS新闻","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180321105506149_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180321105506149_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1544591/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1544591/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK0175","BK0183","BK0187","BK1191","BK0096","BK0188","600196","BK0196","02196","BK1515","BK1593","BK0012","BK0060","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}